Výsledky vyhledávání - "Lawrence B. Berk"

RTOG 0631 Phase II/III Study of Image-Guided Stereotactic Radiosurgery for Localized (1-3) Spine Metastases: Phase II Results

Autor: Samuel, Ryu, Stephanie L, Pugh, Peter C, Gerszten, Fang-Fang, Yin, Robert D, Timmerman, Ying J, Hitchcock, Benjamin, Movsas, Andrew A, Kanner, Lawrence B, Berk, David S, Followill, Lisa A, Kachnic

Publikováno v: International journal of radiation oncology, biology, physics. 81(2)

The phase II component of RTOG 0631 assessed the feasibility and safety of spine radiosurgery (SRS) for localized spine metastases in a cooperative group setting.Patients with 1-3 spine metastasis with a Numerical Rating Pain Scale (NRPS) score ≥ 5

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d0097e3393b9a99dbaec403db80ee6bf
https://pubmed.ncbi.nlm.nih.gov/23864755

Zobrazit plný text záznamu

Pathophysiology and management of radiation-induced xerostomia

Autor: Lawrence B, Berk, Anand T, Shivnani, William, Small

Publikováno v: The journal of supportive oncology. 3(3)

Radiotherapeutic treatment of head and neck cancer patients often causes long-term dysfunction involving their salivary function, swallowing capabilities, and taste. Salivary gland dysfunction from radiation therapy is often the most unpleasant side

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::669adbdc645f338cbf64dc70ee1aa269
https://pubmed.ncbi.nlm.nih.gov/15915822

Zobrazit plný text záznamu

Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: Report of RTOG 0517

Autor: Jerry Derdel, W. Demas, Christopher A. Peters, Gwen Wyatt, Michael J. Seider, Afshin Rashtian, James E. Clarkson, Sean F. Cleary, Cathy L. Clausen, Stephanie Shook, Ashok Ramalingam, Rachel Rabinovitch, Lisa A. Kachnic, Lawrence B. Berk, M. Tomblyn, Corey J. Langer

Publikováno v: Journal of Clinical Oncology. 30:TPS9150-TPS9150

TPS9150 Background: Skeletal related events (SREs) diminish quality of life (QOL) as well as overall survival (OS) in patients with bone metastases, a common event in breast, lung and prostate cancer. SREs can be reduced or delayed by the use of bisp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7d1553080121725e9e387f04dfe690e8
https://doi.org/10.1200/jco.2012.30.15_suppl.tps9150

Zobrazit plný text záznamu

Conference

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání